 |
 |
|
|
RESÚMENES MAYO 2005 |
Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers
(Requiere estar conectado a internet.
Haga un click en la información del journal)
Birth dimensions and risk of depression in adulthood: cohort study of Danish men born in 1953
Merete Osler, Merete Nordentoft, Anne-Marie Nybo Andersen
The British Journal of Psychiatry (2005) 186: 400-403
Distinctive neurocognitive effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in major depression
Svenja C. Schulze-Rauschenbach, Uta Harms, Thomas E. Schlaepfer,
Wolfgang Maier, Peter Falkai, and Michael Wagner
The British Journal of Psychiatry (2005) 186: 410-416
Charles H. Kellner, Max Fink, Rebecca Knapp, Georgios Petrides, Mustafa
Husain, Teresa Rummans, Martina Mueller, Hilary Bernstein, Keith Rasmussen,
Kevin O’Connor, Glenn Smith, A. John Rush, Melanie Biggs, Shawn McClintock,
Samuel Bailine, and Chitra Malur
Am J Psychiatry 162:977-982,
May 2005
Activity and
Connectivity of Brain Mood Regulating Circuit in Depression: A Functional
Magnetic Resonance Study
Amit Anand, Yu Li,
Yang Wang, Jingwei Wu, Sujuan Gao, Lubna Bukhari, Vincent P. Mathews, Andrew
Kalnin and Mark J. Lowe
Biological Psychiatry.
Volume 57, Issue 10, 15 May 2005, Pages 1079-1088
Chronic Depression. Medication
(Nefazodone) or Psychotherapy (CBASP) Is Effective When the Other Is Not
Alan
F. Schatzberg, A. John Rush, Bruce A. Arnow, Phillip L. C. Banks, Janice A.
Blalock, Frances E. Borian, Robert Howland, Daniel N. Klein, James H. Kocsis,
Susan G. Kornstein, Rachel Manber, John C. Markowitz, Ivan Miller, Philip T.
Ninan, Barbara O. Rothbaum, Michael E. Thase, Madhukar H. Trivedi, Martin B.
Keller
Arch Gen Psychiatry. 2005;62:513-520
Efficacy
of escitalopram in patients with severe depression: a pooled analysis
Llorca PM, Azorin JM, Despiegel N, Verpillat P
Int J Clin Pract. 2005 Mar;59(3):268-75
Reversed
diurnal variation in depression: associations with a differential antidepressant
response, tryptophan: large neutral amino acid ratio and serotonin transporter
polymorphisms
Joyce PR, Porter RJ, Mulder RT, Luty SE, McKenzie JM, Miller AL, Kennedy MA
Psychol Med. 2005 Apr;35(4):511-7
Inhibition of CYP2D6 Activity by Bupropion
Kotlyar, Michael; Brauer, Lisa H.; Tracy,
Timothy S.; Hatsukami, Dorothy K.; Harris, Jennifer; Bronars, Carrie A.; Adson,
David E
Journal
of Clinical Psychopharmacology. 25(3):226-229, June 2005
Accelerating Symptom-Reduction in Late-Life Depression. A Double-Blind, Randomized, Placebo-Controlled Trial of Sleep Deprivation
Charles F. Reynolds III, Gwenn S. Smith, Mary Amanda Dew, Benoit H.
Mulsant, Mark D. Miller, Maryann Schlernitzauer, Jacqueline A. Stack, Patricia
R. Houck, and Bruce G. Pollock
Am J Geriatr Psychiatry
13:353-358, May 2005
The outcome of
anxiety disorders in older people at 6-year follow-up: results from the
Longitudinal Aging Study Amsterdam
J.
Schuurmans, H. C. Comijs, A. T. F. Beekman, E. de Beurs, D. J. H. Deeg, P. M.
G. Emmelkamp, R. van Dyck
Acta Psychiatrica Scandinavica. Volume 111 Issue
6 Page 420 - June 2005
Sertraline in
generalized anxiety disorder: efficacy in treating the psychic and somatic
anxiety factors
A.
A. Dahl, A. Ravindran, C. Allgulander, S. P. Kutcher, C. Austin, T. Burt
Acta Psychiatrica Scandinavica. Volume 111 Issue
6 Page 429 - June 2005
Adjunctive bright
light in non-seasonal major depression: results from patient-reported symptom
and well-being scales
K.
Martiny, M. Lunde, M. Undén, H. Dam, P. Bech
Acta Psychiatrica Scandinavica. Volume 111 Issue
6 Page 453 - June 2005
Joyce T.
Bromberger, Howard M. Kravitz, Hsiao-Lan Wei, Charlotte Brown, Ada Owens Youk,
Adriana Cordal, Lynda H. Powell and Karen A. Matthews
General Hospital Psychiatry. Volume 27, Issue 3,
May-June 2005, Pages 200-208
Brian P. Miller,
William Perry, Christine Y. Moutier, Shannon K. Robinson and David Feifel
General Hospital Psychiatry. Volume 27, Issue 3,
May-June 2005, Pages 218-221
Francisco A.
Moreno, Helen Macey, and Brian Schreiber
J Clin Psychiatry 2005;66:555-558
Eduard Vieta,
Salvador Ros, José Manuel Goikolea, Antonio Benabarre, Ekaterina Popova, Mercè
Comes, Jorge Capapey, and José Sánchez-Moreno
J Clin Psychiatry 2005;66:575-578
Boris Nemets, Yuly
Bersudsky, and R. H. Belmaker
J Clin Psychiatry 2005;66:586-590
Jordan F. Karp,
John Scott, Patricia Houck, Charles F. Reynolds III, David J. Kupfer, and Ellen
Frank
J Clin Psychiatry 2005;66:591-597
An 8-Week Open-Label Trial of a 6-Day Course of
Mifepristone for the Treatment of Psychotic Depression
George M. Simpson,
Adel El Sheshai, Nasser Loza, Steven J. Kingsbury, Mohamed Fayek, Ahmed Rady,
and Waleed Fawzy
J Clin Psychiatry 2005;66:598-602
Mark Zimmerman,
Michael A. Posternak, Naureen Attiullah, Michael Friedman, Robert J. Boland,
Scott Baymiller, Stacie Lauro Berlowitz, Shahzad Rahman, Kirsten K. Uy, Steve
Singer, and Iwona Chelminski
J Clin Psychiatry 2005;66:603-610
Analyses of Treatment-Emergent Mania With
Olanzapine/Fluoxetine Combination in the Treatment of Bipolar Depression
Paul E. Keck, Jr.,
Sara A. Corya, Lori L. Altshuler, Terence A. Ketter, Susan L. McElroy, Michael
Case, Susan D. Briggs, and Mauricio Tohen
J Clin Psychiatry 2005;66:611-616
Open-Label Adjunctive Zonisamide in the Treatment of
Bipolar Disorders: A Prospective Trial
Susan L. McElroy,
Trisha Suppes, Paul E. Keck, Jr., David Black, Mark A. Frye, Lori L. Altshuler,
Willem A. Nolen, Ralph W. Kupka, Gabriele S. Leverich, Jorg Walden, Heinz
Grunze, and Robert M. Post
J Clin Psychiatry 2005;66:617-624
The effects of high-dose and low-dose tryptophan depletion on mood and cognitive functions of remitted depressed patients
Linda Booij, A. J. Willem Van der Does, P. M. Judith Haffmans, Wim J.
Riedel, Durk Fekkes, Marc J. B. Blom
Journal of Psychopharmacology, Vol. 19, No. 3, 267-275
(2005)
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential
C. H. Ashton, P. B. Moore, P. Gallagher, A. H. Young
Journal of
Psychopharmacology, Vol. 19, No. 3, 293-300 (2005)
Psychological
illness is commonly associated with functional gastrointestinal disorders and
is important to consider during patient consultation: a population-based study
Ture Alander, Kurt Svardsudd,
Sven-Erik Johansson and Lars Agreus
BMC Medicine 2005, 3:8;13 May 2005
Can a subgroup
of OCD patients with motor abnormalities and poor therapeutic response be
identified?
Roland Mergl,
Paraskevi Mavrogiorgou, Georg Juckel, Michael Zaudig and
Ulrich Hegerl
Psychopharmacology
2005; Volume 179, Number 4: 826 - 837
Effects
of sertraline on depressive symptoms and attentional and executive functions in
major depression
Constant EL, Adam S, Gillain B, Seron X, Bruyer R, Seghers A
Depress Anxiety. 2005 May 9;21(2):78-89 [Epub ahead of
print]
Lithium
concentration correlates with QTc in patients with psychosis.
Mamiya K, Sadanaga T,
Sekita A, Nabeyama Y, Yao H, Yukawa E
J Electrocardiol. 2005 Apr;38(2):148-51
Pharmacotherapy of bipolar mixed states
Stephanie Krüger, L
Trevor Young and Peter Bräunig
Bipolar Disorders. Volume 7 Issue 3 Page
205 - June 2005
Jonathan Savitz,
Mark Solms and Rajkumar Ramesar
Bipolar Disorders. Volume 7 Issue 3 Page
216 - June 2005
Natalie L Rasgon,
Lori L Altshuler, Lynn Fairbanks, Shana Elman, Jose Bitran, Rodrigo Labarca,
Mohammed Saad, Ralph Kupka, Willem A Nolen, Mark A Frye, Trisha Suppes, Susan L
McElroy, Paul E Keck Jr, Gabriele Leverich, Heinz Grunze, Joerg Walden, Robert
Post and Jim Mintz
Bipolar Disorders. Volume 7 Issue 3 Page
246 - June 2005
Mani N Pavuluri,
David B Henry, Julie A Carbray, Michael W Naylor and Philip G Janicak
Bipolar Disorders. Volume 7 Issue 3 Page
266 - June 2005
Andrea Fagiolini,
David J Kupfer, Azadeh Masalehdan, John A Scott, Patricia R Houck and Ellen
Frank
Bipolar Disorders. Volume 7 Issue 3 Page
281 - June 2005
Drug-drug
interactions as a determinant of elevated lithium serum levels in daily
clinical practice
Ingeborg Wilting,
Kristian LL Movig, Marieke Moolenaar, Yechiel A Hekster, Jacobus RBJ Brouwers,
Eibert R Heerdink, Willem A Nolen and Antoine CG Egberts
Bipolar Disorders. Volume 7 Issue 3 Page
274 - June 2005
Hypothalamic-Pituitary-Adrenal Axis Activity and Sleep in
Posttraumatic Stress Disorder
Christian Otte, Maryann Lenoci,
Thomas Metzler, Rachel Yehuda, Charles R Marmar and Thomas C Neylan
Neuropsychopharmacology (2005) 30, 1173-1180
Plasma Concentrations of Neuroactive Steroids before and
after Electroconvulsive Therapy in Major Depression
Thomas C Baghai, Flavia di
Michele, Cornelius Schüle, Daniela Eser, Peter Zwanzger, Augusto Pasini, Elena
Romeo and Rainer Rupprecht
Neuropsychopharmacology (2005) 30, 1181-1186
Antidepressants
and sleep: a qualitative review of the literature
Wilson S, Argyropoulos S
Relation of
C-reactive protein to stroke, cognitive disorders, and depression in the
general population: systematic review and meta-analysis
Hsu-Ko Kuo,
DrChung-Jen Yen, Chia-Hsuin Chang, Chen-Ko Kuo, Jen-Hau Chen and Farzaneh
Sorond
The
Lancet neurology. Volume 4, Issue 6, June 2005, Pages 371-380
N. KENNEDY,
B. EVERITT, J. BOYDELL, J. VAN OS, P. B. JONES and R.
M. MURRAY
Psychological Medicine (2005), 35:6:855-863
Relationship
between Mirtazapine Dose, Plasma Concentration, Response, and Side Effects in
Clinical Practice
Grasmader K, Verwohlt PL,
Kuhn KU, Frahnert C, Hiemke C, Dragicevic A, von Widdern O, Zobel A, Maier W,
Rao ML
Pharmacopsychiatry. 2005 May;38(3):113-7
A screening
study of antidepressant treatment rates and mood symptoms in pregnancy
S. M. Marcus,
H. A. Flynn, F. Blow and K. Barry
Archives
of Women's Mental Health 2005; Volume 8, Number 1: 25 - 27
Exposure
measures applied to the bioequivalence of two sustained release formulations of
bupropion
Midha KK, Rawson MJ, McKay G, Hubbard JW
Int J Clin Pharmacol Ther. 2005 May;43(5):244-54
Lachlan A.
McWilliams, Brian J. Cox and Gordon J.G. Asmundson
Journal
of Anxiety Disorders. Volume 19, Issue 6, 2005, Pages 626-641
Gail A. Bernstein,
Ann E. Layne, Elizabeth A. Egan and Lara P. Nelson
Journal
of Anxiety Disorders. Volume 19, Issue 6, 2005, Pages 658-672